The Center for Regenerative Medicine (CReM) at Boston University Medical Center is offering a five-day course that will focus on deriving, maintaining, characterizing and differentiating human induced pluripotent stem cells (hiPSCs). Small class size will enable researchers to learn the entire process of reprogramming from somatic cell preparation, to reprogramming methodologies, iPSC identification, isolation and characterization, and current approaches to their directed differentiation into endodermal and lung lineages.
NIH has developed a recorded Webinar to assist applicants to the 2018 Funding Opportunity Announcements for the Regenerative Medicine Innovation Project (RMIP) with preparing the most responsive applications possible.
The MyoSeeds Research Grants Program will support research focused on basic biology of the heart and cardiomyopathies. Priority research areas for funding will be announced prior to each cycle. Priorities for the 2018-2019 Funding Cycle are focused on hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
Pre-application letters of intent are due by October 14, 2018, and grant selection notification and awards will occur no later than December 31, 2018.
To provide the PCTC with a mechanism to quickly award small grants to junior faculty (less than 5 years from their appointment to Assistant Professor), Research Associates, Graduate Students, Fellows and Postdocs to support a well-defined specific aim. The aim should involve at least one of the following, with priority given to proposals that incorporate two:
1. The application of new technology to an existing translational research question
Online registration for the 2nd Annual NHLBI Progenitor Cell Translational Consortium (PCTC) Meeting in New York, NY (Thursday, September 27, 2018 and Friday, September 28, 2018) is now closed. We require a picture and brief description of your work for registration. These will be placed in the electronic booklet published on the PCTC website so colleagues with similar interests can identify you.
Drs. Bursac, Jackman and Li show that a combination of low-rate (0.2 Hz) contractile activity and thyroid hormone (T3) supplementation significantly promote structural and functional maturation of engineered rat cardiac tissues (cardiobundles). [04Aug2018 Acta Biomater]
Drs. Jianyi Zhang and E. Dale discuss ATP generation and utilization in the energy starved, failing heart. [19Jul2018 Circulation Research: VIEWPOINTS]
Drs. Gautam Bandyopadhyay, Heidie Huyck, Ravi Misra, Jeffrey Whitsett, and colleagues report novel methods that simultaneously isolate four major pulmonary cell populations from pediatric human lung. [05Jul2018 American Journal of Physiology - Lung Cellular and Molecular Physiology]
Drs. Jianyi Zhang, Wuqiang Zhu, Milica Radisic, and Gordana Vunjak-Novakovic provide a compendium of state-of-the-art developments in the fields of cardiovascular tissue engineering and challenges associated with their clinical use. [05Jul2018 Circulation Research: Regenerative Cardiology Compendium]
Drs. Chia-Min Liao, Somdutta Mukherjee, and colleagues reported that modulating GATA6 expression enhances the production of lung progenitors from human stem cell sources. [11Jun2018 JCI The Journal of Clinical Investigation]
